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In Ayurvedic practice, Triphala is widely used in gastric problems including constipation, large intestinal inflammation 
and colitis. The present research was planned to assess the ameliorative effects of Triphala formulations in reducing the 
magnitude and severity of ulcerative colitis. Triphala formulations prepared by mixing three fruits, Haritaki (Terminalia 
chebula), Bibhitaki (Terminalia belerica) and Amlaki (Emblica officinalis) in different ratios i.e., 1:1:1 (Triphala equal) and 
1:2:4 (Triphala unequal) as per classical references. Wistar albino rats were administered with two ml of acetic acid 
(4% v/v) in intra-colonic lumen for induction of colitis. The efficacy of Triphala was measured on various parameters 
namely, in vivo fluid absorption in tied-off colon, ulcer score and colonic mucosal parameters. The degree of alteration in 
colonic fluid transport was significantly reversed by Triphala equal, Triphala unequal and sulphasalzine as standard drug. 
Triphala formulations significantly attenuated the nitric oxide (NO), myeloperoxidase (MPO) and lipid peroxidation 
(malondialdehyde MDA) levels in mucosa of rat colon. Pre-treatment with Triphala unequal formulation attenuated the 
severity of the colonic macroscopic damage score, histologic injury and counteracted the depletion of glutathione and 
superoxide dismutase activity hence, reduced the oxidative stress in colonic mucosa. Triphala unequal formulation has better 
protective effects. Outcomes of the present study reveal the usefulness of Triphala formulations in attenuating the colonic 
inflammation in experimental-induced ulcerative colitis. 
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Ulcerative colitis is an inflammatory bowel disease 
(IBD), limited to colon characterized by inflammation 
and mucosal disruption. It is a chronic and relapsing 
disorder, pathogenesis of IBD remains unclear even 
though, decontrolled immune system accompanied by 
environmental and genetic factors affects the 
beginning and advancement of disease1. 5-
aminosalicylic preparations are clinically used drug 
for treatment of IBD but having certain adverse 
effects, particularly when administered at higher dose 
or on repeated administration for longer time2. This 
provides alternate of using herbal formulations to treat 
IBD and associated symptoms3. 
Triphala is classified as rasayana (rejuvenator) and 
is said to promote longevity, well beings and immune 
system. The rasayana property of Triphala is well 
elucidated by Network Pharmacology plot which may 
suggest the multi-target approach of Triphala4. As per 
Charaka, Triphala is Tridoshik rasayana, having 
balancing effect on the three Doshas, a constitutional 
components human body5. It is widely practiced for 
GI tract disorders such as constipation, digestion 
related problems, poor food assimilation and large 
bowel inflammatory diseases6. It has anti-
inflammatory7, anti-oxidants8 and intestinal 
cytoprotective9 properties owing to its major 
phytoconstituents.  
Triphala generally consists of dried pericarp of three 
fruits namely, Terminalia chebula Retz. (Haritaki), 
Terminalia belerica (Gaertn) Roxb. (Bibhitaka) and 
Emblica officinalis Gaertn. (Amalaki or Indian 
Gooseberry) fruits in equal ratio (1:1:1)10 while some 
authors advocate formulation using 1:2:4 ratio of 
Haritaki, Bhibhitaka and Amalaki11,12. Previous 
researches also confirmed the role of customary 
prepared Triphala formulation in dextran sodium 
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sulphate13 and 2,4,6-trinitrobenzene sulfonic acid 
(TNBS)14 induced colitis in rats. However, probable 
modulatory role of Triphala formulations prepared as 
per classical concepts by mixing the fruits in different 
ratios has not been yet verified in colon inflammation 
in acetic acid-induced colitis in rats. Therefore, the 
present work was planned with an aim to assess the 
efficacy of Triphala formulations prepared with two 
different ratios on experimental colitis in rats. 
 
Materials and Methods  
Drugs and chemicals 
T. chebula (Haritaki), T. belerica (Bibhitaka) and 
E. officinalis (Amalaki) fruits were collected from its 
natural habitat, authenticated and specimens 
preserved in the Institute. Triphala equal and Triphala 
unequal formulations were prepared using equal ratio 
(1:1:1) and unequal ratio (1:2:4) of Haritaki, 
Bhibhitaka and Amalaki. For biochemical parameters, 
chemicals and reagents used were of analytical 
reagent (AR) grade.  
 
Animals 
Healthy wistar albino rats weighing 200±20 g were 
selected in the research study. Temperature and 
relative humidity maintained as per standard 
husbandry conditions and illumination controlled to 
sequence of 12 h light and dark. Pelleted rat/mice diet 
“Amrut” brand and purified drinking water provided 
ad libitum. An approval for the study protocol was 
obtained from Institutional Animal Ethics Committee 
(IAEC/LMCP/282). 
 
Experimental design  
Total 40 rats were selected based on body weight 
and randomly distributed in to five groups (n=8) in 
way to minimum variation in mean body weight 
between groups. Normal control group (I) and Colitis 
control group (II), treated with vehicle as 1% (w/v) 
carboxymethyl cellulose solution in water. In a 
previous work, 5 mL/kg, 1% (w/v) carboxymethyl 
cellulose has been reported to have no influence on 
experimental-induced colitis in rats15. Drug treated 
groups (III and IV) received Triphala equal (540 
mg/kg) and Triphala unequal (540 mg/kg) 
formulations respectively for 7 days. Standard drug 
group (V), sulafasalazine (100 mg/kg) administered 
on 5th, 6th and on 7th day, 1 h prior to induction of 
ulcerative colitis16.  
Rats were deprived of food for overnight but 
allowed to drinking water before induction of acetic 
acid-induced colitis as explained by MacPherson and 
Pfeiffer17. Briefly, to fasted albino rats, under light 
ether anesthesia, medical grade polyethylene tube (2 
mm diameter) inserted in to colon and the tip of tube 
reach to 8 cm proximal to anus. 4% (v/v) acetic acid 
solution prepared in distilled water and 2 mL was 
instilled in to lumen of colon, thereafter acidic 
solution was neutralized after contact of 10 seconds. 
In control group, rats instilled with phosphate buffer 
saline in same volume. On 8th day after colonic fluid 
absorption study, rats were sacrificed. Colonic 
segment was excised from each albino rat, cleaned of 
extra tissue, rinsed with saline and further used for 
macroscopic damage, biochemical parameters and 
histopathological studies.  
 
Colonic fluid absorption- In vivo study 
The tied-off colon procedure18 was performed in 
anesthetized rats (urethane, 1.2 g/kg body weight, ip) 
on warm table. Lapratomy was done and 2 cm distal 
colon from the cecocolic junction was ligated. The 
colonic stuffs were washed away out with of saline 
(20+20 ml, 37ºC), then dried off with injecting air 
(20+20 mL). A second ligature was placed 1 cm 
above the rectal plaque. 1 mL tyrode solution (37ºC) 
was injected to colon proximal end and then ligature 
closed. The opening was sutured after placing the 
colon in abdominal cavity. After one hour of 
experiment, rat was sacrificed and tied off colon was 
excised. The residual fluid was collected and 
accurately weighed. The change in the volume 
(µL/h.g wet tissue) was measured and subtracted from 
its initial weight; positive values indicate the 
absorption while negative values treated as secretion. 
As per previous study, colon tissue biochemical 
parameters were not altered after colonic fluid 
absorption study19.  
 
Colonic macroscopic damage  
Colonic segment was dissected, adherent tissue 
removed, split out longitudinally and rinsed with 
chilled saline. Macroscopic damage score by 
independent investigator was given ranging from 0 to 
10 scale20 depending upon severity of colonic 
destruction in each rat. The wet colon weight, length 
and weight/length ratio was determined. About 2 g 
load was applied to the colon for length dimension.  
 
Biochemical analysis 
Longitudinal segments of colon stored at -20ºC 
immediately after excision and afterwards subjected 




to biochemical parameters. The measured parameters 
were protein21, myeloperoxidase (MPO) activity and 
expressed as units/g tissue (one unit of activity 
calculated to degrading 1 µmol peroxide/min at 
37°C)22, glutathione23, nitric oxide (NO) was 
measured by the acidic Griess reaction24, superoxide 
dismutase activity expressed as units/mg protein25 
(one unit of activity calculated to inhibition of 
reaction rate by 50% per minute) and lipid 
peroxidation (LPO) evaluated by measuring quantity 
of malondialdehyde (MDA) and expressed as nmol of 
MDA/g tissue26.  
 
Statistical analysis 
The results are presented as mean ± SEM (standard 
error of mean) with n = 8 animals in each group. 
Statistical analysis was done using ANOVA (One 
way analysis of variance) followed by Dunnett’s 
multiple ‘t’ test to compare the mean of quantitative 
variables between groups. The minimal standards of 
significance was considered as p<0.05. 
 
Results and Discussion 
Colonic administration of acetic acid produced 
experimental colitis in albino rats is one of the well-
known and consistent models which have similarity to 
acute inflammation in human intestine27. The rat 
colon instilled with acetic acid showed symptoms of 
colitis with severe inflammation in colonic mucosa, 
ulcerations and lesions with blood spots, as shown by 
increase in damage score on macroscopic evaluation. 
Colon wet weight increased while length decreased as 
revealed by significant increase in weight/length ratio 
(mg/cm) in colitis control group (Table 1). Prior 
treatment of Triphala formulation having unequal 
ratio and sulfasalazine reduced the severity of 
macroscopic ulceration and colonic damage score at 
significant level compared to colitis control group.  
Ulcerative colitis accompanying inflammation of 
mucosa associated with symptoms of diarrhea. 
Therefore, the diminishing  in vivo colonic absorption 
of fluid mainly reveals the initial phase of ulcerative 
colitis with damage of epithelial lining20. In normal 
control group, there was net absorption of fluid in 
tied-off colonic loop represented by positive sign. 
However, inflammation of colonic mucosa in acetic 
acid colitis group intensely affected the in vivo 
colonic fluid absorption to net secretion represented 
by negative sign (Table 1). Both Triphala 
formulations and sulfasalazine significantly 
attenuated the acetic acid-induced alteration in fluid 
transport and exhibited net absorption of colonic 
fluid. In previous studies, many flavonoids are stated 
to reduce the intestinal secretion and its motility28 and 
well known flavonoid quercitrin also reversed the 
mucosal injury after chronic diarrhea in rats29. 
Triphala having good amount of flavanoid may be 
responsible for its protective effects on colonic 
mucosal membrane13. 
Acetic acid-induced colitis in experimental model 
associated with oxidative stress in inflammed colonic 
mucosa30. Present study showed inflammed colonic 
mucosa associated with significant increase in MDA, 
MPO and NO in colonic mucosa along with reduced 
amount of antioxidant parameters such as superoxide 
dismutase activity and glutathione level in 
comparison with control group (Table 2). Increased 
MPO activity suggests the neutrophil recruitment in 
damaged colonic mucosa of rats31. Significant 
decrease in colonic MPO activity in both Triphala 
formulations treated groups may be attributed to its 
anti-inflammatory effect7.  
Triphala has powerful antioxidants effect which 
may reduce the oxidative stress in inflammed colonic 
mucosa colon14 as revealed by significant reduction in 
the thiobarbituric acid reactive substances such as 
MDA which is a good indicator of LPO26. The free 
radical scavenging activity of Triphala may be due to 
presence of well-known phytoconstituents particularly 
gallic acid (phenolic compound)32. In another study, 
flavanoid extracted from Emblica officinalis reported 
to reduce the generation of MDA in albino rats33. 
Table 1 — Effect of Triphala formulations on damage score, in vivo fluid absorption and weight and length ratio in albino rats 
Groups Damage score W/L ratio (mg/cm) In vivo fluid absorption (µL/h.g tissue) 
Control 0 95.61±3.64 396.66±11.66 
Colitis control 9.06±0.78* 135.44±3.08* -74.33±03.48* 
Triphala equal 8.63±0.73 130.93±1.82 20.33±17.66 # 
Triphala unequal  6.41±0.78 # 125.80±3.01 68.33±44.75 # # 
Sulfasalazine  6.46±0.52 # 122.64±2.39 # 143.33±13.01 # # # 
Data: Mean ± SEM, n=8 per group 
*p<0.01 vs control group; # p<0.05, ## p<0.01 vs colitis control group (One way ANOVA followed by Dunnett’s test) 




Thus, the findings of this research work are in 
conformity with previous annotations. The reduction 
in NO level in inflamed mucosa by both Triphala 
formulations also confirm with the earlier research 
work34. The reduction in effect of NO may be due to 
the presence of ascorbic acid which is available in 
rich amount in Amalaki35.  
Decrease in glutathione content suggests the 
excessive generation of free radicals in mucosa of 
ulcerative colitis in rats36. Triphala unequal 
formulation significantly restored the glutathione and 
superoxide dismutase in colonic mucosa of albino 
rats. Earlier study also supported the protective role of 
superoxide dismutase during colitis in rodent model37. 
Flavonoids and tannoid principles of Triphala 
formulation may be responsible for increased level of 
antioxidant parameters, superoxide dismutase and 
glutathione which may protect against free radicals-
induced changes in colon of rats33.  
Emblica officinalis is well known for its anti-
oxidant and free radical scavenging effects owing to 
enhanced ascorbic acid, gallic acid, ellagic acid and 
flavanoid contents. T. belerica contains high quantity 
of phenolics particularly gallic acid along with ellagic 
acid which is responsible for its antioxidant effects8. 
Earlier report showed that, ellagic acid prevents the 
experimental-induced colitis in rats due to its free 
radical scavenging effects38. Triphala formulation is 
very popular for its tannin rich content and due its 
astringent property may protect the membrane 
integrity of epithelial lining in colon of rats39.  
The present data indicates that, flavonoid present in 
Triphala with other bioactives as ascorbic acid, 
tannoid principles and phenolics may have 
contributed significantly to the anti-oxidant and 
beneficial effects observed against experimental-
induced colitis in albino rats. Thus, Triphala 
formulations, especially those with unequal ratio, can 
be considered as an interesting approach in 
attenuating the colon inflammation in experimental 
ulcerative colitis in albino rats. 
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